Expert Opinion on Drug Safety, Volume 21, Issue 2 (2022)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Safety, Volume 21, Issue 2 (2022)

See all volumes and issues
Vol 23, 2024 Vol 22, 2023 Volume 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Drug safety evaluation

Article
Efficacy and safety evaluation of safinamide as an add-on treatment to levodopa for parkinson’s disease
Kanako Kurihara, Takayasu Mishima, Shinsuke Fujioka & Yoshio Tsuboi
Pages: 137-147
Published online: 15 Oct 2021
AbstractforEfficacy and safety evaluation of safinamide as an add-on treatment to levodopa for parkinson’s disease | Full Text | References | PDF (683 KB) | EPUB
  • 402 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Safety of sebelipase alfa for the treatment of lysosomal acid lipase deficiency
Fatih Ezgü
Pages: 149-155
Published online: 22 Oct 2021
AbstractforSafety of sebelipase alfa for the treatment of lysosomal acid lipase deficiency | Full Text | References | PDF (248.4 KB) | EPUB
  • 139 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Safety of ramucirumab treatment in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein
Chih-Chieh Yen & Chia-Jui Yen
Pages: 157-166
Published online: 28 Oct 2021
AbstractforSafety of ramucirumab treatment in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein | Full Text | References | PDF (2 MB) | EPUB | Supplemental
  • 191 Views
  • 1 CrossRef citations
  • 0Altmetric

Meeting highlights

Meeting report: an exploration into the scientific and regulatory aspects of pharmaceutical drug quality in the United States
Bridget M. Flavin, Laura E. Happe & Randy C. Hatton
Pages: 167-170
Published online: 31 Dec 2021
AbstractforMeeting report: an exploration into the scientific and regulatory aspects of pharmaceutical drug quality in the United States | Full Text | References | PDF (171 KB) | EPUB
  • 132 Views
  • 2 CrossRef citations
  • 0Altmetric

Review

Review
Safety considerations with new antibacterial approaches for chronic bacterial prostatitis
Gianpaolo Perletti, Alberto Trinchieri, Konstantinos Stamatiou & Vittorio Magri
Pages: 171-182
Published online: 06 Aug 2021
AbstractforSafety considerations with new antibacterial approaches for chronic bacterial prostatitis | Full Text | References | PDF (394.5 KB) | EPUB
  • 174 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Current treatment of recurrent pericarditis: safety considerations and future directions
Massimo Imazio
Pages: 183-190
Published online: 30 Aug 2021
AbstractforCurrent treatment of recurrent pericarditis: safety considerations and future directions | Full Text | References | PDF (2.3 MB) | EPUB
  • 272 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Safety of treating acute liver injury and failure
Miren García-Cortés, Aida Ortega-Alonso, Raúl J. Andrade & on behalf of the Spanish Group for the Study of Drug-Induced Liver Disease (Grupo de Estudio para las Hepatopatías Asociadas a Medicamentos GEHAM)
Pages: 191-203
Published online: 22 Jul 2021
AbstractforSafety of treating acute liver injury and failure | Full Text | References | PDF (599.9 KB) | EPUB
  • 253 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Assessing intravitreal anti-VEGF drug safety using real-world data: methodological challenges in observational research
Giulia Scondotto, Salvatore Crisafulli, Ippazio Cosimo Antonazzo, Gianni Virgili, Gianluca Trifirò & Janet Sultana
Pages: 205-214
Published online: 27 Jul 2021
AbstractforAssessing intravitreal anti-VEGF drug safety using real-world data: methodological challenges in observational research | Full Text | References | PDF (333.9 KB) | EPUB
  • 264 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Safety of non-hormonal medications for managing hot flashes
Pasquale De Franciscis, Maurizio Guida, Antonio Schiattarella, Gaetano Riemma & Nicola Colacurci
Pages: 215-221
Published online: 28 Jul 2021
AbstractforSafety of non-hormonal medications for managing hot flashes | Full Text | References | PDF (334.5 KB) | EPUB
  • 200 Views
  • 3 CrossRef citations
  • 0Altmetric

Systematic Review

Review
Gastroenterological safety of IL-17 inhibitors: a systematic literature review
Bénédicte Caron, Jean-Yves Jouzeau, Pierre Miossec, Nadine Petitpain, Pierre Gillet, Patrick Netter & Laurent Peyrin-Biroulet
Pages: 223-239
Published online: 06 Aug 2021
AbstractforGastroenterological safety of IL-17 inhibitors: a systematic literature review | Full Text | References | PDF (415 KB) | EPUB
  • 957 Views
  • 8 CrossRef citations
  • 0Altmetric

systematic review and meta-analysis

Review
Effect of Acetaminophen use during pregnancy on adverse pregnancy outcomes: a systematic review and meta-analysis
Caroline T. Castro, Romana S. Gama, Marcos Pereira, Marcio G. Oliveira, Tatiane S. Dal-Pizzol, Mauricio L. Barreto & Djanilson B. Santos
Pages: 241-251
Published online: 10 Jan 2022
AbstractforEffect of Acetaminophen use during pregnancy on adverse pregnancy outcomes: a systematic review and meta-analysis | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 501 Views
  • 1 CrossRef citations
  • 0Altmetric

Original research

Article
Improving the data quality of spontaneous ADR reports: a practical example from Malta
Marta Zuccarelli, Benjamin Micallef, Dianne Butler, Anthony Serracino-Inglott & John-Joseph Borg
Pages: 253-268
Published online: 22 Oct 2021
AbstractforImproving the data quality of spontaneous ADR reports: a practical example from Malta | Full Text | References | PDF (398 KB) | EPUB
  • 141 Views
  • 3 CrossRef citations
  • 0Altmetric

Original Research

Article
Systemic quinolones and risk of retinal detachment I: analysis of data from the US FDA adverse event reporting system
Mohamed Kadry Taher, Abdallah Alami, Christopher A. Gravel, Derek Tsui, Lise M. Bjerre, Franco Momoli, Donald Mattison & Daniel Krewski
Pages: 269-276
Published online: 24 Oct 2021
AbstractforSystemic quinolones and risk of retinal detachment I: analysis of data from the US FDA adverse event reporting system | Full Text | References | PDF (515.5 KB) | EPUB
  • 351 Views
  • 3 CrossRef citations
  • 0Altmetric

Research Article

Article
Association between cyclin-dependent kinase 4/6 inhibitors and venous thromboembolism: analysis of F.A.E.R.S. data
Ming-Ming Yan, Shu-Shan Wu, Yu-Peng Qi, Zi-Ran Li, Qian Zhang, Hui Zhao, Ming-Kang Zhong & Xiao-Yan Qiu
Pages: 277-283
Published online: 28 Sep 2021
AbstractforAssociation between cyclin-dependent kinase 4/6 inhibitors and venous thromboembolism: analysis of F.A.E.R.S. data | Full Text | References | PDF (758.9 KB) | EPUB | Supplemental
  • 657 Views
  • 4 CrossRef citations
  • 0Altmetric

Letter to the Editor

Investigating the root cause of N-nitrosodimethylamine formation in metformin pharmaceutical products
Nasr Eldin Hussein Nasr, Metwaly Gamel Metwaly, Eman Osama Ahmed, Ahmed Roshdy Fares & Aliaa Nabil ElMeshad
Pages: 285-287
Published online: 07 Oct 2021
First Page PreviewforInvestigating the root cause of N-nitrosodimethylamine formation in metformin pharmaceutical products | Full Text | References | PDF (1.2 MB) | EPUB
  • 916 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Reply to the article ‘Investigating the root cause of N- nitrosodimethylamine formation in metformin pharmaceutical products’
Markus Mintert, Michael Kerry, Dean Lee, June Zhu, Koudi Zhu, Barbara Serr, Mark Dreibelbis, Elizabeth Tocce & Meinolf Brackhagen
Page: 289
Published online: 29 Sep 2021
CitationforReply to the article ‘Investigating the root cause of N- nitrosodimethylamine formation in metformin pharmaceutical products’ | Full Text | PDF (87.8 KB) | EPUB
  • 641 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles